Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach-Reference-Cited by-同舟云学术

Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach

Published:2024-04-27 Issue:2 Volume:15 Page:375-404
ISSN:1878-5085
Container-title:EPMA Journal
language:en
Short-container-title:EPMA Journal

Author:

Jia Wenshuang,Li Na,Wang Jingjing,Gong Xiaoxia,Ouedraogo Serge Yannick,Wang Yan,Zhao Junkai,Grech Godfrey,Chen Liang,Zhan Xianquan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13167-024-00359-3.pdf

Reference152 articles.

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

2. Devouassoux-Shisheboran M, Genestie C. Pathobiology of ovarian carcinomas. Chin J Cancer. 2015;34(1):50–5. https://doi.org/10.5732/cjc.014.10273.

3. Gupta S, Nag S, Aggarwal S, Rauthan A, Warrier N. Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - a review. J Ovarian Res. 2019;12(1):103. https://doi.org/10.1186/s13048-019-0579-0.

4. Roett MA, Evans P. Ovarian cancer: an overview. Am Fam Physician. 2009;80(6):609–16.

5. Yu L, Ding Y, Wan T, Deng T, Huang H, Liu J. Significance of CD47 and its association with tumor immune microenvironment heterogeneity in ovarian cancer. Front Immunol. 2021;12: 768115. https://doi.org/10.3389/fimmu.2021.768115.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling;EPMA Journal;2024-07-13